X. Jin et al. / Journal of Molecular Catalysis A: Chemical 374–375 (2013) 22–26
23
N
ı = 30.0, 29.3; HRMS (Q-Tof MS, ES+): m/z = 721.2175, calcd. for
+
C47H35O N P [M+H] : 721.2168.
2
2 2
N
ꢀ
2
.4. Preparation and characterization of (S)-5,5 -diimidazole
BINAP (4)
PPh2
PPh2
The synthesis and purification of 4 followed the published
method [28]. A mixture of 2 (0.2 g, 0.26 mmol) and phenylsi-
PPh2
PPh2
◦
lane (1.5 mL, 12.2 mmol) was heated to 130 C. Three portions of
trichlorosilane (3 × 0.4 mL) were added by syringe after 1 h, 3 h, and
1
5 h and the reaction was stirred for 2 h. The mixture was cooled
and the volatiles were removed under reduced pressure to afford
a white solid. The solid was washed with degassed cyclohexane,
filtered and evaporated. The 4 was obtained in quantitative yield.
N
N
imidazole-tagged BINAP
20
1
[
˛] D: −90.4 (c 0.5, DMF); H NMR (500.0 MHz, CDCl ): ı = 6.91
3
(S)-BINAP
(d, J = 8.5 Hz, 2H), 6.97 (t, J = 7.6 Hz, 2H), 6.99–7.25 (m, 20H), 7.36
(
7
d, J = 7.0 Hz, 2H), 7.40 (s, 2H), 7.47 (s, 2H), 7.53 (d, J = 8.5 Hz, 2H),
1
3
.58 (d, J = 8.5 Hz, 2H), 8.23 (s, 2H); C NMR (125.7 MHz, CDCl ):
3
Scheme 1. Structure of the original and the functionalized BINAP ligands.
ı = 121.8, 124.6, 125.2, 128.4, 128.5, 128.6, 129.1, 129.3, 132.3,
32.7, 132.8, 132.9, 133.8, 134.3, 134.4, 134.5, 135.7, 136.4, 138.7,
1
3
1
spectrometry. The data of Ru loss were measured by ICP-AES on a
IRIS Istrepid II XSP apparatus.
144.0; P NMR (202.4 MHz, CDCl3): ı = 13.1; HRMS (Q-Tof MS,
ES+): m/z = 755.2497, calcd. for C50H37N4P2 [M+H] : 755.2488.
+
ꢀ
2.5. Preparation and characterization of (S)-5-imidazole BINAP
2
.2. Preparation and characterization of (S)-5,5 -dibromo
(
5)
BINAPO (1)
The 5 was synthesized as described process for 4. [˛]20D: −127.1
The synthesis and purification followed the published procedure
1
1
(c 0.5, DMF); H NMR (500.0 MHz, CDCl ): ı = 6.65 (d, J = 8.0 Hz, 1H),
6
(
[
28]. H NMR (500.0 MHz, CDCl ): ı = 6.61 (dd, J = 8.5, 7.5 Hz, 2H),
3
3
.90 (t, J = 7.5 Hz, 1H), 6.90–7.25 (m, 22H), 7.34–7.42 (m, 3H), 7.45
dd, J = 8.5, 3.0 Hz, 1H), 7.51 (s, 1H), 7.59 (dd, J = 8.5, 2.0 Hz, 1H),
7.69 (s, 1H), 7.86 (d, J = 8.0 Hz, 1H), 7.95 (d, J = 8.5 Hz, 1H), 8.75
6
2
2
1
1
.71 (d, J = 8.5 Hz, 2H), 7.23–7.41 (m, 16H), 7.54 (dd, J = 11.5, 8.5 Hz,
H), 7.64 (d, J = 7.5 Hz, 2H), 7.67–7.71 (m, 4H), 8.30 (dd, J = 8.5,
.0 Hz, 2H); 13C NMR (125.7 MHz, CDCl ): ı = 122.8, 126.0, 126.7,
3
1
3
(
s, 1H); C NMR (125.7 MHz, CDCl ): 118.5, 120.2, 120.8, 123.4,
26.8, 127.9, 128.2, 129.4, 131.2, 131.4, 131.9, 132.0, 132.3, 132.4,
3
3
1
124.8, 126.2, 126.7, 127.9, 128.1, 128.2, 128.3, 128.8, 130.4, 131.1,
132.7, 132.9, 133.0, 133.3, 133.6, 134.2, 134.3, 134.5, 135.7, 135.9,
32.5, 133.5, 134.4, 142.7; P NMR (202.4 MHz, CDCl ): ı = 28.6;
3
+
ESI-MS (+): [M+H] = 813.1.
3
1
1
36.6, 136.9, 139.6, 143.2, 145.8; P NMR (202.4 MHz, CDCl ):
3
ı = −13.7, −14.2; HRMS (Q-Tof MS, ES+): m/z = 689.2277, calcd. for
ꢀ
2
.3. Preparation and characterization of (S)-5,5 -diimidazole
+
C
4
H
35
N P [M+H] : 689.2270.
7
2 2
BINAPO (2) and (S)-5-imidazole BINAPO (3)
ꢀ
2.6. Preparation of 6, 7 and their corresponding Ru(II) dibromide
complexes 6-Ru and 7-Ru in situ [29]
The (S)-5,5 -diimidazole BINAPO (2) was synthesized by a amino
acid promoted Cu-catalyzed C–N bond formation. A mixture of
1
(3.6 g, 4.4 mmol), imidazole (6.1 g, 89.0 mmol), K CO3 (2.5 g,
2
Under an argon atmosphere, imidazole-tagged BINAP ligands
4 or 5 (0.0031 mmol) were dissolved in 0.5 mL of degassed CH2Cl2.
Then 0.9 L (0.0062 mmol) or 0.45 L (0.0031 mmol) of an aqueous
HBr solution (40%) was added for ligand 4 or for ligand 5, respec-
1
8.0 mmol), CuI (0.35 g, 1.8 mmol), and l-proline (0.42 g, 3.6 mmol)
◦
in 70 mL of DMSO was stirred at 140 C for 48 h under an argon
atmosphere. The cooled mixture was filtered off, and ethyl acetate
was added to the filtrate. The organic layer was washed with
brine, dried over Na SO , and concentrated in vacuum. The residual
solid was purified by a silica gel column chromatography (elu-
◦
tively. The solution was allowed to stir for 30 min at 25 C after
2
4
which the CH Cl2 was removed. To the residue were added 1.0 mg
2
of ruthenium precursor Ru[(2-methylallyl)2 (COD)] (0.0031 mmol)
and 0.5 mL of degassed acetone. Next, 0.9 L of an aqueous HBr
solution (40%) was added. The catalyst solution was allowed to
stir for 30 min after which the acetone was removed to give the
catalysts 6-Ru or 7-Ru. The catalysts 6-Ru or 7-Ru were used imme-
diately for the hydrogenation of -keto esters.
ent: EtOAc/EtOH/H O = 15/2/1) to afford the pure 2 as white solid
2
(
1.7 g, 49.1%) and 3 as a byproduct (0.78 g). The characterization
2
5
1
of 2: [˛] D: −187.3 (c 0.5, DMF); H NMR (500.0 MHz, CDCl ):
3
ı = 6.97 (dd, J = 8.5, 7.5 Hz, 2H), 7.02 (d, J = 8.5 Hz, 2H), 7.22–7.45
(m, 22H), 7.50 (dd, J = 11.5, 9.0 Hz, 2H), 7.62–7.69 (m, 6H), 7.82 (s,
13
2
1
1
H); C NMR (125.7 MHz, CDCl ): ı = 121.8, 121.9, 125.2, 128.0,
28.1, 128.2, 129.5, 129.7, 130.2, 130.7, 131.5, 131.8, 132.0, 132.4,
32.9, 133.8, 134.0, 134.2, 138.4, 143.0;
3
3
1
2.7. General procedure for the homogeneous Ru-catalysed
asymmetric hydrogenation of ˇ-keto esters in methanol
P NMR (202.4 MHz,
CDCl ): ı = 29.1; HRMS (Q-Tof MS, ES+): m/z = 787.2393, calcd.
for C50H37O N P [M+H] : 787.2386; The characterization of 3:
3
+
2
4 2
25
1
Typically, the preceding catalysts 6-Ru (0.0031 mmol) or 7-Ru
[
(
˛] D: −198.7 (c 0.5, DMF); H NMR (500.0 MHz, CDCl ): ı = 6.77
3
(0.0031 mmol) were dissolved in 2 mL of degassed methanol under
d, J = 8.5 Hz, 1H), 6.86 (t, J = 8.0 Hz, 1H), 6.90 (dd, J = 8.5, 7.5 Hz,
an argon atmosphere. The -keto esters (substrate/Ru = 1000) were
added to the solution of catalyst. Next, the reaction mixture was
transferred to a 60 mL autoclave. The hydrogenation was carried
out under 4 MPa pressure of hydrogen at 60 C for 20 h. The con-
versions and ee value were determined by GC on a lipodex A
1
H), 7.04 (d, J = 8.5 Hz, 1H), 7.20–7.50 (m, 22H), 7.60–7.72 (m, 5H),
.80 (s, 1H), 7.86 (d, J = 8.0 Hz, 1H), 7.90 (dd, J = 8.5, 2.0 Hz, 1H);
7
13
C NMR (125.7 MHz, CDCl ): ı = 121.5, 121.8, 124.9, 126.0, 126.8,
3
◦
1
1
1
27.3, 127.6, 127.9, 128.0, 128.1, 128.4, 129.5, 129.7, 130.1, 131.2,
31.3, 131.9, 132.0, 132.3, 132.4, 132.6, 133.3, 133.5, 133.7, 133.9,
3
1
(25m × 0.25 mm) chiral capillary column.
34.0, 134.3, 134.5, 142.3, 143.7; P NMR (202.4 MHz, CDCl ):
3